We are currently updating the OP Help Center content for the release of OP 14.19 or OP 19. OP 19 is a member of the certified OP 14 family of products (official version is 14.19.1), which you may see in your software (such as in Help > About) and in the Help Center tabs labeled 14.19. You may also notice that the version number in content and videos may not match the version of your software, and some procedural content may not match the workflow in your software. We appreciate your patience and understanding as we make these enhancements.

Objective 8: Public Health and Clinical Data Registry Reporting

Previously known as Meaningful Use Stage 3, CMS renamed the EHR Incentive Programs to Promoting Interoperability in April 2018. The program has evolved over time as providers have adopted EHRs and is focused on interoperability across EHRs and improving patient access to health information, hence the name Promoting Interoperability.

At time of attestation you will need a screenshot of the QIC and a download of the SQL to a CSV file. All information should be saved to your "Book of Evidence". This can be an electronic folder of all documentation for the reporting period.

Objective 8: Public Health and Clinical Data Registry Reporting

Objective 8 requires a practice to attest the eligible professional is in active engagement with a public health agency or clinical data registry. The eligible professional must meet two of the five measures for this objective.

Measure 1: Immunization Registry Reporting

  • Must be in active engagement to submit immunization data and receive immunization forecasts and histories from the immunization registry.
  • Exclusions that apply:
    • Do not administer immunizations.
    • No immunization registry is capable of accepting the specific standards required to meet the objectives definition at the start of the reporting period.
    • No immunization registry available to receive immunization data six months prior to the start of the reporting period.

Measure 2: Syndromic Surveillance Reporting

  • Must be in active engagement with a public health agency to submit syndromic surveillance data.
  • Exclusions that apply:
    • Syndromic surveillance data is not collected.
    • No public health agency is capable of accepting the specific standards required to meet the objectives definition at the start of the reporting period.
    • No public health agency is available to receive data six months prior to the start of the reporting period.

Measure 3: Electronic Case Reporting

  • Must be in active engagement with a public health agency to submit case reporting of reportable conditions.
  • Exclusions that apply:
    • Do not diagnose or directly treat any reportable diseases for which data is collected.
    • No public health agency is capable of accepting the specific standards required to meet the objectives definition at the start of the reporting period.
    • No public health agency is available to receive data six months prior to the start of the reporting period.

Measure 4: Public Health Registry Reporting

  • Must be in active engagement with a public health agency to submit data to a public health registry.
  • Exclusions that apply:
    • Do not diagnose or directly treat any disease or condition associated with a public health registry.
    • No public health agency is capable of accepting the specific standards required to meet the objectives definition at the start of the reporting period.
    • No public health agency is available to receive data six months prior to the start of the reporting period.

Measure 5: CDR (Clinical Data Registry) Reporting

  • Must be in active engagement to submit data to a Clinical Data Registry.
  • Exclusions that apply:
    • Do not diagnose or directly treat any disease or condition associated with a Clinical Data Registry.
    • No Clinical Data Registry is capable of accepting the specific standards required to meet the objectives definition at the start of the reporting period.
    • No Clinical Data Registry is available to receive data six months prior to the start of the reporting period.

Active Engagement Options

Option 1:

Completed Registration to Submit Data: The EP registered to submit data with the PHA or, where applicable, the CDR to which the information is being submitted; registration was completed within 60 days after the start of the EHR reporting period; and the EP is awaiting an invitation from the PHA or CDR to begin testing and validation. This option allows providers to meet the measure when the PHA or the CDR has limited resources to initiate the testing and validation process. Providers that have registered in previous years do not need to submit an additional registration to meet this requirement for each EHR reporting period.

Option 2:

Testing and Validation: The EP is in the process of testing and validation of the electronic submission of data. Providers must respond to requests from the PHA or, where applicable, the CDR within 30 days; failure to respond twice within an EHR reporting period would result in that provider not meeting the measure.

Option 3:

Production: The EP has completed testing and validation of the electronic submission and is electronically submitting production data to the PHA or CDR.

Note: For any entity that the practice would like to exchange data with as it pertains to Public Health Reporting or Syndromic Surveillance, it is the practice's responsibility to enter into Active Engagement under one of the three options above. Once the practice is in Active Engagement Option 2 you will need to submit an interface request with the Client Account Management Team. Office Practicum will provide a quote, and manage it like all other interface requests. The practice will incur a charge for the interface unless it was included as part of the original contract. In addition, Office Practicum will require time to develop the interface.